ENVESTNET ASSET MANAGEMENT INC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$1,278,266
-8.2%
35,856
+18.8%
0.00%0.0%
Q2 2023$1,392,250
+37.2%
30,181
+19.2%
0.00%
Q1 2023$1,015,051
-9.3%
25,313
+4.8%
0.00%
-100.0%
Q4 2022$1,119,379
+20.5%
24,161
+7.7%
0.00%0.0%
Q3 2022$929,000
-35.8%
22,428
-7.5%
0.00%0.0%
Q2 2022$1,446,000
-16.4%
24,237
+1.8%
0.00%0.0%
Q1 2022$1,730,000
+3.5%
23,817
+19.8%
0.00%0.0%
Q4 2021$1,672,000
+8.0%
19,878
+15.8%
0.00%0.0%
Q3 2021$1,548,000
+9.9%
17,169
+16.3%
0.00%0.0%
Q2 2021$1,408,000
-25.9%
14,765
-11.5%
0.00%0.0%
Q1 2021$1,901,000
+44.6%
16,692
+75.7%
0.00%0.0%
Q4 2020$1,315,000
+108.7%
9,499
+23.8%
0.00%0.0%
Q3 2020$630,000
+44.2%
7,670
+37.2%
0.00%
Q2 2020$437,000
+99.5%
5,590
+13.5%
0.00%
Q1 2020$219,000
+1360.0%
4,926
+1616.4%
0.00%
Q3 2017$15,000
-62.5%
287
-56.2%
0.00%
Q2 2017$40,000
-13.0%
656
-2.5%
0.00%
Q1 2017$46,000
+4.5%
673
+6.8%
0.00%
Q4 2016$44,0006300.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2021
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 75,000$5,084,0002.52%
COLUMBIA WANGER ASSET MANAGEMENT LLC 1,237,825$83,900,0001.18%
CAPITAL INTERNATIONAL LTD /CA/ 206,718$14,011,0000.91%
Cormorant Asset Management, LP 75,000$5,084,0000.74%
Capital International Sarl 107,450$7,283,0000.63%
Rock Springs Capital Management LP 159,750$10,828,0000.62%
Opus Point Partners Management, LLC 12,201$827,0000.61%
Hood River Capital Management LLC 109,629$7,431,0000.56%
Aureus Asset Management, LLC 50,740$2,927,0000.51%
ROCKEFELLER FINANCIAL SERVICES INC 374,663$25,395,0000.51%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders